INTRODUCTION Recruitment of sufficient and diverse participants into clinical research for
Alzheimer's disease and related dementias remains a formidable challenge. The primary …

The 2012 National Plan to Address Alzheimer's Disease set an ambitious goal: to both
prevent and effectively treat Alzheimer's disease by 2025. To reach this goal, tens of …

Inefficient and delayed recruitment into clinical trials in Alzheimer disease are major
obstacles impeding progress in the discovery of more effective therapeutic strategies to …

Alzheimer disease (AD) research faces challenges to successful enrollment, especially to
clinical trials and biomarker studies. Failure to recruit the planned number of participants in a …

Background The identification and enlistment of suitable participants into clinical studies is
often challenging, requiring a large commitment of time and staff resources. The recruitment …

Abstract Introduction The Alzheimer Society embarked on a project to improve ways that the
60 provincial and local Societies in Canada can work with local researchers to support …

Background The recruitment challenges for MCI and AD subjects into clinical trials are well
known, and this is particularly true for early phase studies. Currently, only 10-20% of all …

Recruiting persons with dementia for clinical trials can be challenging. Building on a guide
initially developed to assist primary-care-based memory clinics in their efforts to support …

Background: Low participation in clinical trials is a major challenge to advancing clinical
Alzheimer's disease (AD) research and care. Factors influencing recruitment to AD trials are …

Potential participant registries are tools to address the challenge of slow recruitment to
clinical research. In particular, registries may aid recruitment to secondary prevention clinical …